Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control

Tehran University of Medical Sciences

Status and phase: Completed; Phase 4

Conditions: Paroxysmal Supraventricular Tachycardia

Treatments: Drug: Verapamil

Study type: Interventional

Funder types: Other

Identifiers

NCT01655316

16062

Details and patient eligibility

About

PSVT is a common rhythm disorder in emergency department which can be recurrent in some cases.

Intravenous Adenosine is the drug of choice in PSVT control in acute settings but is a very short acting agent.

Providing a complementary medication to decrease the rate of recurrence of PSVT after its initial control will be promising.

This study evaluates the role of the oral Verapamil in recurrence control of PSVT in emergency situations.

Enrollment: 90 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age>18 years old
• PSVT on emergency department presentation

Exclusion criteria

• Instability in hemodynamic status
• Allergy to Verapamil

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: Single Blind

---

90 participants in 1 patient group

Verapamil

Experimental group

Description:

40 mg Verapamil Per Oral

Treatment:

Drug: Verapamil